BioStem Technologies, Inc. (BSEM) Debt Components
- 2026-06-30: Notes Payable, CurrentUSD $1.00M; Notes PayableUSD $1.00M; Long-term DebtUSD (m); Debt Instrument, Unamortized DiscountUSD (m).
- 2026-06-30: Notes Payable, CurrentUSD (m); Notes PayableUSD (m); Long-term DebtUSD $0.00; Debt Instrument, Unamortized DiscountUSD (m).
- 2025-12-31: Notes Payable, CurrentUSD $3.00M; Notes PayableUSD $3.00M; Long-term DebtUSD (m); Debt Instrument, Unamortized DiscountUSD (m).
- 2025-12-31: Notes Payable, CurrentUSD (m); Notes PayableUSD (m); Long-term DebtUSD $0.00; Debt Instrument, Unamortized DiscountUSD (m).
BioStem Technologies, Inc. Debt Components
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Notes Payable, Current USD | Notes Payable USD | Long-term Debt USD | Debt Instrument, Unamortized Discount USD |
|---|---|---|---|---|
| 2026-06-30 | $1.00M | $1.00M | (m) | (m) |
| 2026-06-30 | (m) | (m) | $0.00 | (m) |
| 2025-12-31 | $3.00M | $3.00M | (m) | (m) |
| 2025-12-31 | (m) | (m) | $0.00 | (m) |
| 2024-12-31 | $3.96M | (m) | $150.00K | $63.61K |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |